Dr. Karen Reckamp talks about ways to incorporate biomarkers for the treatment of lung cancer with immunotherapy into clinical practice at the 2017 American Society of Clinical Oncology Annual Meeting, held June 2–6 in Chicago.
As part of our coverage of the 2017 ASCO Annual Meeting, we discuss homologous recombination deficiency in ovarian cancer and PARP inhibitors.
In this interview we discuss decision making in the treatment of metastatic renal cell carcinoma.
Ahead of the 2017 ASCO Annual Meeting, we discuss the discontinuation of TKIs in some chronic myeloid leukemia patients.
In this interview ahead of ASCO 2017 we discuss the physical and cognitive effects of androgen deprivation therapy in older men treated for prostate cancer.
Ahead of the 2017 ASCO Annual Meeting, we discuss how to approach treatment for older patients with lung cancer.
With Decades of Perspective, Craig Henderson Observes That Treatment of Breast Cancer Has Come a Long Way
In this interview we discuss important developments in the diagnosis and management of breast cancer and more.
In this interview we discuss a study that looked at the effect of an 8-week exercise intervention on treatment side effects for patients with prostate cancer.
In this interview we discuss pain management for cancer patients who are at high risk of opioid abuse.
In this interview we discuss humanistic medicine and some of the skills that physicians need in order to have open communication with their cancer patients, which can improve the quality of cancer care.